• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.

作者信息

Liao Ying-Chieh, Hsieh Yu-Cheng, Hung Chen-Ying, Huang Jing-Long, Lin Ching-Heng, Wang Kuo-Yang, Wu Tsu-Juey

机构信息

Cardiovascular Center, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, Taiwan.

出版信息

Int J Cardiol. 2013 Oct 12;168(5):4805-7. doi: 10.1016/j.ijcard.2013.07.036. Epub 2013 Jul 23.

DOI:10.1016/j.ijcard.2013.07.036
PMID:23890884
Abstract
摘要

相似文献

1
Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.他汀类药物治疗可降低心力衰竭患者室性心律失常、心源性猝死和死亡的风险：一项基于全国人群的队列研究。
Int J Cardiol. 2013 Oct 12;168(5):4805-7. doi: 10.1016/j.ijcard.2013.07.036. Epub 2013 Jul 23.
2
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.
3
[Heart failure and treatment of ventricular arrhythmias].[心力衰竭与室性心律失常的治疗]
Praxis (Bern 1994). 1999 Feb 4;88(6):215-22.
4
Beta-blockers, ventricular arrhythmias, and sudden death in heart failure: not as simple as it seems.β受体阻滞剂、室性心律失常与心力衰竭中的猝死：并非看上去那么简单。
Eur Heart J. 2000 Aug;21(15):1214-5. doi: 10.1053/euhj.2000.2257.
5
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.胺碘酮用于充血性心力衰竭合并无症状室性心律失常患者。充血性心力衰竭抗心律失常治疗生存试验。
N Engl J Med. 1995 Jul 13;333(2):77-82. doi: 10.1056/NEJM199507133330201.
6
Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.心力衰竭与植入式心脏复律除颤器患者的电击风险：室性心律失常触发因素（TOVA）研究结果
Circulation. 2004 Mar 23;109(11):1386-91. doi: 10.1161/01.CIR.0000120703.99433.1E. Epub 2004 Mar 1.
7
Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.300例经历过心脏骤停复苏的缺血性心脏病患者复发性室性心律失常或死亡的决定因素：来自莱顿院外心脏骤停研究的数据
J Cardiovasc Electrophysiol. 2005 Oct;16(10):1049-56. doi: 10.1111/j.1540-8167.2005.50006.x.
8
Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.接受心脏再同步治疗的心力衰竭合并心室传导延迟患者的长期生存情况。
Am J Cardiol. 2007 Jan 15;99(2):232-8. doi: 10.1016/j.amjcard.2006.07.087. Epub 2006 Nov 17.
9
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
10
Low-dose amiodarone in severe chronic heart failure.低剂量胺碘酮治疗重度慢性心力衰竭
Indian Heart J. 1996 Jul-Aug;48(4):361-4.

引用本文的文献

1
Recent Advances in Inflammation-Associated Epicardial Adipose Tissue for Atrial Fibrillation Patients.炎症相关的心外膜脂肪组织在房颤患者中的最新进展
Rev Cardiovasc Med. 2025 Jul 22;26(7):36598. doi: 10.31083/RCM36598. eCollection 2025 Jul.
2
Evaluating the efficacy, safety, and predictors of failure following cardiac resynchronization therapy in a developing country: an ambispective, multi-center study.在一个发展中国家评估心脏再同步治疗后的疗效、安全性及失败预测因素：一项回顾性与前瞻性相结合的多中心研究。
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):148-162. doi: 10.21037/cdt-24-408. Epub 2025 Feb 25.
3
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases.
针对心血管疾病炎症的新型治疗方法和即将开展的临床试验。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2371-2395. doi: 10.1161/ATVBAHA.124.319980. Epub 2024 Oct 10.
4
Fir(e)ing the Rhythm: Inflammatory Cytokines and Cardiac Arrhythmias.激发节律：炎性细胞因子与心律失常
JACC Basic Transl Sci. 2023 Feb 15;8(6):728-750. doi: 10.1016/j.jacbts.2022.12.004. eCollection 2023 Jun.
5
Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress.心脏保护剂抗心律失常作用的潜在机制：影响炎症和氧化应激。
Int J Mol Sci. 2022 Jan 26;23(3):1416. doi: 10.3390/ijms23031416.
6
Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias.他汀类药物治疗与室性心律失常患者的生存改善相关。
Lipids Health Dis. 2019 May 24;18(1):119. doi: 10.1186/s12944-019-1011-x.
7
Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?失代偿性心力衰竭合并室性心律失常：室性心动过速消融术有多大作用？
Curr Heart Fail Rep. 2018 Aug;15(4):201-213. doi: 10.1007/s11897-018-0395-7.
8
Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.瑞舒伐他汀和阿托伐他汀对ST段抬高型心肌梗死患者非持续性室性心动过速的影响：一项回顾性分析
Eur J Clin Pharmacol. 2018 Jan;74(1):29-35. doi: 10.1007/s00228-017-2338-8. Epub 2017 Sep 30.
9
The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.药物治疗在心力衰竭患者心脏性猝死预防中的作用。
Heart Fail Rev. 2016 Jul;21(4):415-31. doi: 10.1007/s10741-016-9546-7.
10
Lipids, statins, and clinical outcomes in heart failure: rethinking the data.心力衰竭中的脂质、他汀类药物与临床结局：重新审视数据
Heart Fail Rev. 2014 Nov;19(6):695-8. doi: 10.1007/s10741-014-9423-1.